Clinical trial
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
NCT00916617
Study timeline
Study start (unknown)2009-06-01Date precision: month
Registry last updated2017-06-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
bapineuzumabDRUG
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00916617 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.